Skip to Main Content

Author Details

Rosa Rademakers
University of Antwerp
1995
385
95
Trey Ideker (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
38091751Neurite-based white matter alterations in MAPT mutation carriers: A multi-shell diffusion MRI study in the ALLFTD consortium.Neurobiol Aging2024
37525358Senile plaque-associated transactive response DNA-binding protein 43 in Alzheimer's disease: A case report spanning 16â¿¿years of memory loss.Neuropathology2024
37831661Uncovering the distinct macro-scale anatomy of dysexecutive and behavioural degenerative diseases.Brain2024
37827570Temporal course of cognitive and behavioural changes in motor neuron diseases.J Neurol Neurosurg Psychiatry2024
36527486Accumulation of TMEM106B C-terminal fragments in neurodegenerative disease and aging.Acta Neuropathol2023
38093787Molecular fragment characteristics and distribution of tangle associated TDP-43 (TATs) and other TDP-43 lesions in Alzheimer's disease.Free Neuropathol2023
37563165Frontotemporal lobar degeneration.Nat Rev Dis Primers2023
37386798Psychotic symptoms in frontotemporal dementia with TDP-43 tend to be associated with type B pathology.Neuropathol Appl Neurobiol2023
37182869Comparison of Clinical, Genetic, and Pathologic Features of Limbic and Diffuse Transactive Response DNA-Binding Protein 43 Pathology in Alzheimer's Disease Neuropathologic Spectrum.J Alzheimers Dis2023
37077569Case report: TMEM106B haplotype alters penetrance of GRN mutation in frontotemporal dementia family.Front Neurol2023
37171891NanoPack2: population-scale evaluation of long-read sequencing data.Bioinformatics2023
37171635Limbic-predominant age-related TDP-43 proteinopathy (LATE-NC) is associated with abundant TMEM106B pathology.Acta Neuropathol2023
37100087C-terminal TMEM106B fragments in human brain correlate with disease-associated TMEM106B haplotypes.Brain2023
37163045Creating the Pick's disease International Consortium: Association study of <i>MAPT</i> H2 haplotype with risk of Pick's disease.medRxiv2023
37327267The SERPINA5 coding variant E228Q does not contribute to clinicopathologic characteristics in Alzheimer's disease: A cross-sectional study.Medicine (Baltimore)2023
36546684APOE2 Exacerbates TDP-43 Related Toxicity in the Absence of Alzheimer Pathology.Ann Neurol2023
36607424Correction to: Accumulation of TMEM106B Câ¿¿terminal fragments in neurodegenerative disease and aging.Acta Neuropathol2023
34823271Concurrent tau pathologies in frontotemporal lobar degeneration with TDP-43 pathology.Neuropathol Appl Neurobiol2022
35790423Differences in Motor Features of <i>C9orf72</i>, <i>MAPT</i>, or <i>GRN</i> Variant Carriers With Familial Frontotemporal Lobar Degeneration.Neurology2022
35810449GRN Mutations Are Associated with Lewy Body Dementia.Mov Disord2022
36632182White-matter abnormalities in presymptomatic <i>GRN</i> and <i>C9orf72</i> mutation carriers.Brain Commun2022
36001141Atypical Alzheimer's disease phenotypes with normal or borderline PET biomarker profiles.J Neurol2022
36056242Identification of TMEM106B amyloid fibrils provides an updated view of TMEM106B biology in health and disease.Acta Neuropathol2022
34918030Shared brain transcriptomic signature in TDP-43 type A FTLD patients with or without GRN mutations.Brain2022
35247328Homotypic fibrillization of TMEM106B across diverse neurodegenerative diseases.Cell2022
35047667Revealing the Mutational Spectrum in Southern Africans With Amyotrophic Lateral Sclerosis.Neurol Genet2022
32843152Underlying genetic variation in familial frontotemporal dementia: sequencing of 198 patients.Neurobiol Aging2021
33568542Association of Mitochondrial DNA Genomic Variation With Risk of Pick Disease.Neurology2021
33709463Loss of Tmem106b leads to cerebellum Purkinje cell death and motor deficits.Brain Pathol2021
33756466Neurobehavioral Characteristics of FDG-PET Defined Right-Dominant Semantic Dementia: A Longitudinal Study.Dement Geriatr Cogn Disord2021
33889947Long-read targeted sequencing uncovers clinicopathological associations for C9orf72-linked diseases.Brain2021
33861770Impact of variant-level batch effects on identification of genetic risk factors in large sequencing studies.PLoS One2021
33635380Latent trait modeling of tau neuropathology in progressive supranuclear palsy.Acta Neuropathol2021
34687211SLITRK2, an X-linked modifier of the age at onset in C9orf72 frontotemporal lobar degeneration.Brain2021
33969528Old age genetically confirmed frontotemporal lobar degeneration with TDP-43 has limbic predominant TDP-43 deposition.Neuropathol Appl Neurobiol2021
34103532A molecular pathology, neurobiology, biochemical, genetic and neuroimaging study of progressive apraxia of speech.Nat Commun2021
34049163FDG-PET in presymptomatic C9orf72 mutation carriers.Neuroimage Clin2021
33433878Lysosomal Dysfunction and Other Pathomechanisms in FTLD: Evidence from Progranulin Genetics and Biology.Adv Exp Med Biol2021
33247623Brain volumetric deficits in MAPT mutation carriers: a multisite study.Ann Clin Transl Neurol2021
33274526Lewy Body Disease is a Contributor to Logopenic Progressive Aphasia Phenotype.Ann Neurol2021
33270986Machine learning suggests polygenic risk for cognitive dysfunction in amyotrophic lateral sclerosis.EMBO Mol Med2021
31272932Individualized atrophy scores predict dementia onset in familial frontotemporal lobar degeneration.Alzheimers Dement2020
32000838Elevated methylation levels, reduced expression levels, and frequent contractions in a clinical cohort of C9orf72 expansion carriers.Mol Neurodegener2020
31810826Age at symptom onset and death and disease duration in genetic frontotemporal dementia: an international retrospective cohort study.Lancet Neurol2020
31784375Clinical and volumetric changes with increasing functional impairment in familial frontotemporal lobar degeneration.Alzheimers Dement2020
31636026The longitudinal evaluation of familial frontotemporal dementia subjects protocol: Framework and methodology.Alzheimers Dement2020
31955222Correction to: A nonsynonymous mutation in PLCG2 reduces the risk of Alzheimer's disease, dementia with Lewy bodies and frontotemporal dementia, and increases the likelihood of longevity.Acta Neuropathol2020
31918955Trajectory of lobar atrophy in asymptomatic and symptomatic GRN mutation carriers: a longitudinal MRI study.Neurobiol Aging2020
31857710Publisher Correction: Exome sequencing in amyotrophic lateral sclerosis implicates a novel gene, DNAJC7, encoding a heat-shock protein.Nat Neurosci2020
31914230Assessment of executive function declines in presymptomatic and mildly symptomatic familial frontotemporal dementia: NIH-EXAMINER as a potential clinical trial endpoint.Alzheimers Dement2020
  • 1 - 50 of 385

Recommended Authors

University of Washington
Career Start Year 2011
Number of shared co-authors 11
Mayo Clinic Florida
Career Start Year 2011
Number of shared co-authors 58
Mayo Clinic
Career Start Year 2010
Number of shared co-authors 70
Royal College of Surgeons in Ireland
Career Start Year 2010
Number of shared co-authors 0
Institute of Psychiatric Phenomics and Genomics (IPPG), LMU University Hospital
Career Start Year 2009
Number of shared co-authors 16
University of Washington
Career Start Year 2009
Number of shared co-authors 7
David Geffen School of Medicine, University of California los angeles
Career Start Year 2007
Number of shared co-authors 24
University of California san francisco
Career Start Year 2006
Number of shared co-authors 15
Center for Translational Research in Neurodegenerative Disease, University of Florida
Career Start Year 2005
Number of shared co-authors 14
National Hospital for Neurology and Neurosurgery
Career Start Year 2005
Number of shared co-authors 17
Center for Genomics and Transcriptomics (CeGaT)
Career Start Year 2004
Number of shared co-authors 10
Cincinnati Children's Hospital Medical Center
Career Start Year 2002
Number of shared co-authors 64
UCL Great Ormond Street Institute of Child Health, University College London
Career Start Year 2001
Number of shared co-authors 61
Baylor College of Medicine
Career Start Year 1998
Number of shared co-authors 44
University of California, San Diego and VA San Diego Healthcare System (D.G.
Career Start Year 1998
Number of shared co-authors 2
The Translational Genomics Research Institute (TGen)
Career Start Year 1998
Number of shared co-authors 93
University of Michigan ann arbor
Career Start Year 1997
Number of shared co-authors 10
University of Pavia
Career Start Year 1996
Number of shared co-authors 15
University of Washington
Career Start Year 1995
Number of shared co-authors 44
University of Oxford
Career Start Year 1993
Number of shared co-authors 11
University of Louisville
Career Start Year 1992
Number of shared co-authors 4
Indiana University School of Medicine
Career Start Year 1992
Number of shared co-authors 40
Institute of Neurology, University College London (UCL)
Career Start Year 1991
Number of shared co-authors 47
UCL Queen Square Institute of Neurology
Career Start Year 1988
Number of shared co-authors 57
Ageing Epidemiology Research Unit, School of Public Health, Imperial College London
Career Start Year 1988
Number of shared co-authors 26
University of Washington School of Medicine
Career Start Year 1988
Number of shared co-authors 3
Universite Libre de Bruxelles (ULB)
Career Start Year 1985
Number of shared co-authors 30
Lou Ruvo Center for Brain Health, Cleveland Clinic
Career Start Year 1980
Number of shared co-authors 86
Sorbonne University, Paris Brain Institute - ICM, Inserm, CNRS
Career Start Year 1975
Number of shared co-authors 30
Houston Methodist Research Institute
Career Start Year 1975
Number of shared co-authors 8

Collaborators

Mayo Clinic Jacksonville
Co-authored papers 177
Mayo Clinic Florida
Co-authored papers 114
Mayo Clinic Rochester
Co-authored papers 106
Mayo Clinic Rochester
Co-authored papers 83
Mayo Clinic Rochester
Co-authored papers 82
Co-authored papers 70
UCSF Weill Institute for Neurosciences, University of California san francisco
Co-authored papers 54
Mayo Clinic
Co-authored papers 43
Weill Institute for Neurosciences, University of California san francisco
Co-authored papers 40
University of British Columbia
Co-authored papers 38
UCSF Weill Institute for Neurosciences, University of California san francisco
Co-authored papers 35
Mayo Clinic Rochester
Co-authored papers 31
Co-authored papers 30
David Geffen School of Medicine, University of California los angeles
Co-authored papers 29
UCSF Weill Institute for Neurosciences, University of California san francisco
Co-authored papers 29
University of Pennsylvania
Co-authored papers 26
UCSF Weill Institute for Neurosciences, University of California san francisco
Co-authored papers 26
Northwestern University Feinberg School of Medicine
Co-authored papers 25
Mayo Clinic Rochester
Co-authored papers 22
Mayo Clinic
Co-authored papers 21
University of California los angeles
Co-authored papers 20
London Health Sciences Centre Parkwood Institute (EF)
Co-authored papers 16
Mayo Clinic
Co-authored papers 16
University of California San Diego
Co-authored papers 15
UCSF Weill Institute for Neurosciences, University of California san francisco
Co-authored papers 14
Mayo Clinic
Co-authored papers 13
Mayo Clinic
Co-authored papers 13
Western University
Co-authored papers 12
German Center for Neurodegenerative Diseases (DZNE).
Co-authored papers 11
Co-authored papers 11